The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Serban Puricel
Showing 1-7 of 7 articles
Long-term follow-up of an extreme kinking of a right coronary artery stenosis treated with a bioresorbable vascular scaffold
Stierlin F,
Puricel S,
Cook S
October 4, 2019 | 10.4244/EIJ-D-18-00441
Midterm clinical outcomes with everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents for percutaneous coronary interventions: a meta-analysis of randomised trials
Cassese S,
Byrne R,
Jüni P,
Wykrzykowska JJ,
Puricel S,
Ndrepepa G,
Schunkert H,
Fusaro M,
Cook S,
Kimura T,
Henriques J,
Serruys P,
Windecker S,
Kastrati A
January 19, 2018 | 10.4244/EIJ-D-17-00492
Biolimus-eluting versus everolimus-eluting stents in coronary artery disease: a pooled analysis from the NEXT (NOBORI biolimus-eluting versus XIENCE/PROMUS everolimus-eluting stent) and COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent) randomised trials
Vlachojannis G,
Puricel S,
Natsuaki M,
Morimoto T,
Smits P,
Kimura T
March 20, 2017 | 10.4244/EIJ-D-16-00773
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with coronary artery disease: three-year follow-up of the COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent) trial
Vlachojannis G,
Smits P,
Hofma S,
Togni M,
Vázquez N,
Valdes M,
Voudris V,
Puricel S,
Slagboom T,
Goy J-J,
den Heijer P,
van der Ent M
July 20, 2015 | 10.4244/EIJV11I3A53
A propensity score-matched comparison between Cardia and Amplatzer PFO closure devices - insights from the SOLUTION registry (Swiss percutaneOus patent foramen ovale cLosUre in recurrent clinical events prevenTION)
Puricel S,
Arroyo D,
Goy J-J,
Praz F,
Palhais N,
Wahl A,
Stauffer J-C,
Togni M,
Berger A,
Meier B,
Cook S
June 19, 2015 | 10.4244/EIJY14M05_05
Long-term comparison of everolimus-eluting and biolimus-eluting stents
Puricel S,
Oberhänsli M,
Guntern P,
Lehmann S,
Goy J-J,
Arroyo D,
Villeneuve H,
Baeriswyl G,
Stauffer J-C,
Togni M,
Cook S
July 26, 2013 | 10.4244/EIJV9I3A55
Clinical outcomes after PCI for acute coronary syndrome in unprotected left main coronary artery disease: insights from the Swiss Acute Left Main Coronary Vessel Percutaneous Management (SALVage) study
Puricel S,
Adorjan P,
Oberhänsli M,
Stauffer J-C,
Moschovitis A,
Vogel R,
Goy J-J,
Muller O,
Eeckhout E,
Togni M,
Wenaweser P,
Meier B,
Windecker S,
Cook S
October 28, 2011 | 10.4244/EIJV7I6A112
1
Latest news
AHEAD OF PRINT
Two-year outcomes after TMVR
FREE ARTICLE - Sebastian Ludwig et al
May 26, 2023
Simultaneous Publications at EuroPCR 2023!
May 12, 2023
NEW ISSUE
Debating Invasive Coronary Testing in INOCA Patients; Single Antiplatelet Therapy After PCI; Ultrasound-Guided Femoral Access in the UNIVERSAL Trial
May 12, 2023
AHEAD OF PRINT
BIOSOLVE-IV registry
FREE ARTICLE - Adrian Wlodarczak et al
May 24, 2023
AHEAD OF PRINT EUROPCR
The EURO SHOCK Trial
FREE ARTICLE - Amerjeet Singh Banning et al
May 19, 2023
AHEAD OF PRINT EUROPCR
Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve (DurAVR)
FREE ARTICLE - Susheel K. Kodali et al
May 19, 2023
AHEAD OF PRINT EUROPCR
TAVI for bicuspid aortic valves with Evolut platform
FREE ARTICLE - Didier Tchétché et al
May 18, 2023
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke